Your browser doesn't support javascript.
loading
An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response.
Chen, Li; Zhang, Haiwei; Li, Moxuan; Wu, Bihao; Zhang, Zhe; Gong, Rui.
Affiliation
  • Chen L; CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Zhang H; University of Chinese Academy of Sciences, Beijing, China.
  • Li M; CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Wu B; CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Zhang Z; University of Chinese Academy of Sciences, Beijing, China.
  • Gong R; CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Front Immunol ; 13: 1005321, 2022.
Article in En | MEDLINE | ID: mdl-36466882
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Limits: Animals Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Limits: Animals Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland